Sulindac can treat diabetes in mice by activating CYP19A1 to synthesize estrogen [55], and multiple clinical data show that the CYP19A1 gene deeply affects plasma zinc levels, urinary zinc levels, susceptibility, and other issues in Chinese type 2 diabetic populations [56,57]. Here, CYP19A1 is linked to diabetes mellitus.